Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06108375
Other study ID # MUSIC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 24, 2023
Est. completion date October 2024

Study information

Verified date May 2024
Source University of Zurich
Contact David Blum, Prof.Dr.med.
Phone +41 43 253 37 42
Email david.blum@usz.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study seeks to assess differences in feasibility and acceptability of music therapy played live and listening to a recording thereof at the palliative care ward of the University Hospital Zurich. As a secondary objective the investigators aim to extend the limited findings on the putative effect of music therapy in palliative care populations derived from objective measures of human autonomic response combined with subjective psychological outcomes to support evidence-based medicine. The investigators will implement a commercially available tracker, the wristband 287-2 by Corsano, to investigate multiple simultaneous biomarkers of autonomic response to music therapy and a recording thereof, such as heart rate, heart rate variability, electrodermal activity and distal body temperature. To investigate subjective quality of life and psychological outcomes, the investigators will administer highly validated and widely used questionnaires, namely the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 15 Palliative Care, the Edmonton Symptom Assessment System and the Hospital Anxiety and Depression Scale.


Description:

The power of music to raise the spirits and to heal the soul should not be underestimated. There is growing recognition of the significance of music as a complementary treatment in palliative care, which is reflected in the growing body of scientific literature on the subject and in the popularly of music therapy among palliative care patients themselves. Palliative care describes the holistic approach in the treatment of patients with advanced or incurable diseases, such as terminal cancer. In addition to conventional medical and nursing care, critical psychological, social and spiritual support is provided in palliative care. To this end, an interdisciplinary team of doctors, nursing staff, physiotherapists, occupational therapists, social workers, psycho-oncologists, chaplains and music therapists is involved. Music therapy is defined as "the systematic use of music within a therapeutic relationship which aims at restoring, maintaining and furthering emotional, physical and mental health". The aim of music therapy in palliative care, in contrast, is to relieve symptoms of distress and improve quality of life among patients in the advanced stages of oncological disease. In Germany, national oncological guidelines currently recommend music therapy as a treatment option to alleviate anxiety and existential fear. Music therapy encompasses both active and receptive techniques. Active techniques involve the patient in the production of music, such that they sing or play a musical instrument, possibly making planned gifts of songs to loved ones or for memorial services, whereas receptive techniques guide the patient in listening to music, both prerecorded as well as performed for them live. In cancer patients, the focus is placed primarily on music-assisted relaxation, generation of imagery, songs and improvisation. This heterogeneity of techniques studied in the literature on music therapy precludes an understanding of precisely what aspects of music therapy are most beneficial. Despite a diversity of approach, findings are promising, which in itself may be an indication as to whether the whole of music therapy is perhaps greater than the sum of its parts. To practice music therapy according to the standards of evidence-based medicine, it is necessary to specify the intervention performed as well as the musical instrument(s) used. Moderators such as individual patient preferences and experience with music also may play an appreciable role; however, these are rarely systematically investigated. Music therapy is conventionally administered by a trained music therapist and individual therapy sessions typically last 20 minutes. Training backgrounds of therapists vary, whereby in the United States a bachelor's degree in music therapy is the minimum requirement and board certification must follow in order for professional practice. Few studies have investigated the efficacy of music therapy in palliative care patients. An emerging body of scientific literature in this clinical population suggests that music therapy may alleviate physical pain as well as psychological, social and emotional suffering. Spiritual needs may particularly benefit from music therapy. Furthermore, a meta-analysis could show significant positive effects of music therapy on psychological wellbeing, physical symptoms and overall quality of life. Music therapy may favour various routine overarching themes in palliative care as well, such as pain management, relaxation, joy, hope, intensified spirituality and improved quality of life and may reduce anxiety and depression. Music therapy may outperform verbal exercises in inducing relaxation and reducing fatigue but not pain. Despite the generally promising findings suggesting a benefit to psychological well-being assessed by subjective methods (e.g., visual analog scales, questionnaires, etc.) there is scant evidence derived from experiments utilizing objective outcome measures (e.g., autonomic response, etc.) with rigorous study design to support the efficacy of music therapy. Findings derived from autonomic data suggest a benefit of music therapy characterized by increased parasympathetic tone accompanying improved subjective ratings of relaxation. Boosted high-frequency heart rate (HR) oscillations coincided with subjective relaxation score from visual analog scale after music therapy. In addition, blood volume pulse amplitude (BVP-A) was increased from baseline to post-therapy, indicating heightened vascular dilation due to greater parasympathetic activation, although just below the threshold of statistical significance (p = 0.07). In another analysis in the same sample, during music therapy higher levels of parasympathetically-mediated HR variability (HRV) were observed. Resting HR and blood pressure (BP) were reduced, whereas relaxation, comfort and happiness were increased. Increases in distal body temperature was observed in a sample of individuals undergoing chemotherapy. Anxiety related to chemotherapy was reduced by music therapy in this sample. The present study seeks to assess differences in feasibility and acceptability of music therapy played live and listening to a recording thereof at the palliative care ward of the University Hospital Zurich. As a secondary objective the investigators aim to extend the limited findings on the putative effect of music therapy in palliative care populations derived from objective measures of human autonomic response combined with subjective psychological outcomes to support evidence-based medicine. The investigators will implement a commercially available tracker, the wristband 287-2 by Corsano, to investigate multiple simultaneous biomarkers of autonomic response to music therapy and a recording thereof, such as heart rate, heart rate variability, electrodermal activity and distal body temperature. To investigate subjective quality of life and psychological outcomes, the investigators will administer highly validated and widely used questionnaires, namely the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 15 Palliative Care, the Edmonton Symptom Assessment System and the Hospital Anxiety and Depression Scale. The proposed risk category of this study is A. Justification for this risk categorization is reflected in the safe and relatively low burden of the study design, which requires the participants to undergo music therapy, complete questionnaires and wear a small wristwatch-like apparatus for a few minutes. Moreover, compared to conventional clinical measurement of human autonomic response, which typically involves skin disinfection and abrading followed by application of adhesive electrodes, the 287-2 wristband by Corsano is comparatively far less invasive and therefore represents diminished burden for the patient during their participation in the study. Music therapy and questionnaires (EORTC QLQ-C15-PAL, ESAS and HADS) are routine tasks for palliative care patients and represent no significant additional burden. In addition, the EORTC QLQ-C15-PAL questionnaire is the validated short-form version of the EORTC QLQ-C30-PAL, whose design objective is reduced patient burden. Furthermore, music therapy and these questionnaires are the standard of care in palliative care. The investigators submit that risk category A is appropriate given these methodological and ethical considerations.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date October 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age >18 years old - Capacity to provide informed consent - Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy on a palliative care ward at the University Hospital Zurich Exclusion Criteria: • Inability to answer a questionnaire due to physical limitations as well as cognitive or linguistic reasons.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
music therapy
music played live by a music therapist
recording
a recording of the same music played by the music therapist

Locations

Country Name City State
Switzerland University Hospital Zurich Zürich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary intervention-specific acceptability questionnaire based on Theoretical Framework of Acceptability assesses intervention acceptability, values 8 - 40, higher = better outcome immediately before and after the intervention
Secondary Edmonton Symptom Assessment System Assesses subjective symptom severity, values 0 - 120, higher = worse outcome immediately before and after the intervention
Secondary European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 15 Palliative Care Assesses subjective quality of life, values 15 - 63, higher = worse outcome immediately before and after the intervention
Secondary Hospital Anxiety and Depression Scale Assesses subjective anxiety and depression, values 0 - 42, higher = worse outcome immediately before and after the intervention
Secondary Qualitative open questions for patients Assesses subjective experience of the intervention immediately before and after the intervention
Secondary Heart rate Heart rate (bpm) is a basic marker of autonomic response and can reflect mortality and disease immediately before and after the intervention
Secondary Heart rate variability Heart rate variability reflects neuro cardiac regulatory capacity and is a strong prognostic marker of mortality and disease immediately before and after the intervention
Secondary Electrodermal activity (µS; skin conductance response) Electrodermal activity is a reliable biomarker of arousal immediately before and after the intervention
Secondary Temperature Thermoregulation is tightly controlled and reacts to vigilance state immediately before and after the intervention
See also
  Status Clinical Trial Phase
Completed NCT04078815 - End-of-life Practices in 2019 vs. 2014
Recruiting NCT04750395 - Comparing Haloperidol and Olanzapine in Treating Terminal Delirium Phase 2
Completed NCT04030910 - 'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life N/A
Completed NCT04568629 - ADJUST: A Study on MDT Prognostication N/A
Completed NCT03520270 - Prevalence of Potentially Inappropriate Treatments
Enrolling by invitation NCT05625854 - Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness N/A
Recruiting NCT04257227 - Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness N/A
Completed NCT04678310 - iLIVE Volunteer Study
Completed NCT04456647 - Parenteral Nutrition Therapy in Patients With Incurable Cancer
Completed NCT02362295 - Prospective National Survey of the Palliative Situation Among Inmates in French Prisons N/A
Terminated NCT03886753 - Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
Active, not recruiting NCT04950608 - Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care Phase 2
Completed NCT03336489 - Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
Completed NCT03392857 - End Of Life in the Critically Ill patiEnt
Completed NCT03697213 - The Surprise Study
Completed NCT01367613 - Open-Label Treatment Extension of Protocol MNTX 302 Phase 3
Recruiting NCT04612738 - Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations N/A
Completed NCT02067572 - A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care N/A
Withdrawn NCT03041571 - Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
Terminated NCT03616639 - Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function Phase 4